Search

Search Constraints

You searched for: Author/Creator Ifrah, Norbert

Search Results

22. Impact of body‐surface area on patients' outcome in younger adults with acute myeloid leukemia. (1st March 2017)

23. Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A french multicenter study. (1st November 2014)

24. Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial. (18th April 2021)

25. NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML. (2nd December 2017)

26. Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemia. Issue 2 (7th December 2017)

27. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial. Issue 7 (July 2018)

28. R‐DHA‐oxaliplatin (R‐DHAOx) versus R‐DHA‐cisplatin (R‐DHAP) regimen in B‐cell lymphoma treatment: A eight‐year trajectory study. (11th May 2020)

29. The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27. (2nd July 2016)

30. The p16INK4A/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome. Issue 4 (April 2015)